[NMusers] RE: Clinical Pharmacology Fellowship, North Carolina

From: Brendan Johnson <Brendan.johnson_at_roivant.com>
Date: Thu, 16 Nov 2017 01:16:43 +0000

Hi nmusers,
Roivant Sciences is seeking candidates for a 1 year clinical pharmacology f=
ellowship program in their Durham, North Carolina, office.
Roivant Sciences is a biopharmaceutical company focused on realizing the fu=
ll value of promising drug candidates and systematically reducing the time =
and cost of delivering new drugs to market. This fellowship will provide a =
broad overview and real-world experience of the drug development process. W=
e are seeking self-motivated graduates who are passionate about pursuing a =
research career within the pharmaceutical industry.

  * This is a 1 year program located in Durham, NC. The estimated start d=
ate is 7/1/2018, or earlier (flexible).
  * The selected fellow is responsible for his/her relocation, housing an=
d transportation.
  * Fellows will be paid a competitive salary and are eligible for compan=
y benefits.

  * High energy, self-directed individuals with excellent communication s=
  * Completed a U.S. based PharmD or PhD degree program in Pharmacokineti=
cs, Biology, Pharmaceutics, or a related field.
  * Candidates must be eligible to work in the US at the time of, and for=
 the duration of their employment. Candidates will be required to furnish e=
vidence of US work authorization.
To see additional details and application form, click this link

or go to Roivant.com and click 'Join us'

Brendan M. Johnson, Ph.D.
Senior Director, Pharmacokinetics
Roivant Sciences, Inc.
324 Blackwell St, Suite 1220,
Durham, NC 27701
office: +1 (919) 425-5710
mobile:+1 (919) 572-9559


This e-mail message (including all attachments) is for the sole use of the =
intended recipient(s) and may contain confidential and privileged informati=
on. If you are not the intended recipient, you must not review, use, disclo=
se, copy, distribute or keep this email, its attachments or the message(s) =
or information contained in it or attached to it. If you are not the intend=
ed recipient, please contact the sender as soon as possible by reply e-mail=
 and thereafter immediately delete this email and destroy all copies of the=
 original message and any attachments. We have taken precautions to minimiz=
e the risk of transmitting software viruses, but we advise you to carry out=
 your own virus checks on any attachment to this message. We cannot accept =
liability for any loss or damage caused by software viruses.

(image/png attachment: image001.png)

Received on Wed Nov 15 2017 - 20:16:43 EST

This archive was generated by hypermail 2.3.0 : Fri Sep 27 2019 - 16:56:55 EDT